The variant E233G of the RAD51D gene could be a low‐penetrance allele in high‐risk breast cancer families without BRCA1/2 mutations
暂无分享,去创建一个
Pilar Zamora | Trinidad Caldés | Ana Osorio | Marina Pollán | Angel Carracedo | Luis Sánchez-Pulido | Javier Benítez | Ana Vega | Miguel de la Hoya | Gloria Ribas | J. Benítez | G. Ribas | Á. Carracedo | L. Sánchez-Pulido | A. Osorio | C. Alonso | O. Díez | R. González-Sarmiento | Á. Ruibal | M. Pollán | R. Rodríguez-López | R. Letón | T. Caldés | M. de la Hoya | P. Zamora | A. Vega | R. Salazar | C. Miner | Cristina Miner | Orland Díez | J. Arias | Rogelio González-Sarmiento | Rocío Letón | Jose Ignacio Arias | Raquel Rodríguez-López | Alvaro Ruibal | Raquel Salazar | Jose Ignacio Martínez | Eva Esteban-Cardeñosa | Carmen Alonso | Miguel Urioste Azcorra | M Eugenia Armengod | E. Esteban-Cardeñosa | J. I. Martínez | M. Urioste Azcorra | M. Armengod | R. Letón | Eva M Esteban-Cardeñosa
[1] Paul D P Pharoah,et al. Variants in DNA double-strand break repair genes and breast cancer susceptibility. , 2002, Human molecular genetics.
[2] J. Benítez,et al. The breast cancer low‐penetrance allele 1100delC in the CHEK2 gene is not present in Spanish familial breast cancer population , 2004, International journal of cancer.
[3] Jong-Soo Lee,et al. hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response , 2000, Nature.
[4] D. Easton,et al. EMGM Abstracts , 2003, Genetic epidemiology.
[5] D. Higgins,et al. T-Coffee: A novel method for fast and accurate multiple sequence alignment. , 2000, Journal of molecular biology.
[6] J. Cigudosa,et al. Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[7] J. Benítez,et al. Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: A high proportion of mutations unique to Spain and evidence of founder effects , 2003, Human mutation.
[8] B. Modan,et al. A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[9] J. Peto,et al. The future of association studies of common cancers , 2003, Human Genetics.
[10] Nazneen Rahman,et al. Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations , 2002, Nature Genetics.
[11] Sandeep Kumar,et al. Dissecting α‐helices: Position‐specific analysis of α‐helices in globular proteins , 1998, Proteins.
[12] I. Ellis,et al. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. , 2002, Histopathology.
[13] David J. Chen,et al. Evidence for Simultaneous Protein Interactions between Human Rad51 Paralogs* , 2000, The Journal of Biological Chemistry.
[14] O. Kallioniemi,et al. A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. , 2002, American journal of human genetics.
[15] I. M. Jones,et al. Identification of 127 amino acid substitution variants in screening 37 DNA repair genes in humans. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[16] S C West,et al. Role of BRCA2 in control of the RAD51 recombination and DNA repair protein. , 2001, Molecular cell.
[17] H. Moch,et al. Tissue microarrays for rapid linking of molecular changes to clinical endpoints. , 2001, The American journal of pathology.
[18] Huan-Xiang Zhou,et al. Electrostatic contributions to T4 lysozyme stability: solvent-exposed charges versus semi-buried salt bridges. , 2002, Biophysical journal.
[19] Douglas F. Easton,et al. Polygenic susceptibility to breast cancer and implications for prevention , 2002, Nature Genetics.
[20] D. Livingston,et al. In search of the tumour-suppressor functions of BRCA1 and BRCA2 , 2000, Nature.
[21] J Chang-Claude,et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. , 1998, American journal of human genetics.